Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,702 | -16,711 | -102,062 | -85,304 | -58,194 |
| Depreciation Amortization | 862 | 362 | 1,685 | 1,726 | 1,087 |
| Accounts payable and accrued liabilities | -677 | 389 | -2,790 | -1,316 | -682 |
| Other Working Capital | -3,836 | -4,175 | 5,339 | 9,626 | 10,532 |
| Other Operating Activity | 4,288 | 1,206 | 19,564 | 16,520 | 7,672 |
| Operating Cash Flow | $-32,065 | $-18,929 | $-78,264 | $-58,748 | $-39,585 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,299 | 25,251 | 65,383 | 57,770 | 35,315 |
| PPE Investments | N/A | N/A | -146 | -133 | -129 |
| Investing Cash Flow | $26,299 | $25,251 | $65,237 | $57,637 | $35,186 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,827 | 8,742 | 135 | 89 | 89 |
| Financing Cash Flow | $8,827 | $8,742 | $135 | $89 | $89 |
| Beginning Cash Position | 21,709 | 21,709 | 34,601 | 34,601 | 34,601 |
| End Cash Position | 24,770 | 36,773 | 21,709 | 33,579 | 30,291 |
| Net Cash Flow | $3,061 | $15,064 | $-12,892 | $-1,022 | $-4,310 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,065 | -18,929 | -78,264 | -58,748 | -39,585 |
| Capital Expenditure | N/A | N/A | -146 | -133 | -129 |
| Free Cash Flow | -32,065 | -18,929 | -78,410 | -58,881 | -39,714 |